Landauer, Inc. is a provider of technical and analytical services to determine occupational and environmental radiation exposure. The Company is a provider of outsourced medical physics services, and a provider of radiology related medical products. The Company operates through three segments: Radiation Measurement, Medical Physics and Medical Products. The Company provides radiation dosimetry services to hospitals, medical and dental offices, universities, national laboratories, nuclear facilities and other industries. Medical physics services are provided through the Company's Landauer Medical Physics (LMP) division. The Company uses LMP as a platform to expand into the medical physics services market, serving domestic hospitals, radiation therapy centers and imaging centers. The Company's Medical Products segment provides medical consumable accessories used in radiology, radiation therapy and image guided surgery procedures.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryHealth Care Services
SectorN/A
Phone+1-708-7557000
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees600
OptionableNot Optionable
Landauer (NYSE:LDR) Frequently Asked Questions
What is Landauer's stock symbol?
Landauer trades on the New York Stock Exchange (NYSE) under the ticker symbol "LDR."
How were Landauer's earnings last quarter?
Landauer Inc (NYSE:LDR) announced its quarterly earnings results on Wednesday, December, 14th. The scientific and technical instruments company reported $0.44 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.42 by $0.03. The scientific and technical instruments company had revenue of $36.80 million for the quarter, compared to analysts' expectations of $38 million. View Landauer's Earnings History.
Has Landauer been receiving favorable news coverage?
Headlines about LDR stock have trended somewhat positive on Saturday, InfoTrie Sentiment reports. InfoTrie scores the sentiment of media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Landauer earned a media sentiment score of 1.5 on InfoTrie's scale. They also gave news coverage about the scientific and technical instruments company a news buzz of 1.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near future.
Who are Landauer's key executives?
Landauer's management team includes the folowing people:
- Michael P. Kaminski, President, Chief Executive Officer, Director
- Daniel J. Fujii, Chief Financial Officer, Vice President, Secretary
- G. Douglas King, Senior Vice President, Chief Information Officer,Administration
- Michael R. Kennedy, Senior Vice President-Strategic Marketing and Product Development
- William G. Dempsey, Non-Executive Chairman of the Board
- Michael T. Leatherman, Director
- Jeffrey Bailey, Independent Director
- Teri G. Fontenot, Independent Director
- David E. Meador, Independent Director
How do I buy shares of Landauer?
Shares of LDR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Landauer's official website?
How can I contact Landauer?
Landauer's mailing address is 2 Science Rd, GLENWOOD, IL 60425-1586, United States. The scientific and technical instruments company can be reached via phone at +1-708-7557000.
MarketBeat Community Rating for Landauer (NYSE LDR)
MarketBeat's community ratings are surveys of what our community members think about Landauer and other stocks. Vote "Outperform" if you believe LDR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LDR will underperform the S&P 500 over the long term. You may vote once every thirty days.
